Literature DB >> 18284447

Chemosensitization of fungal pathogens to antimicrobial agents using benzo analogs.

Jong H Kim1, Noreen Mahoney, Kathleen L Chan, Russell J Molyneux, Gregory S May, Bruce C Campbell.   

Abstract

Activities of conventional antifungal agents, fludioxonil, strobilurin and antimycin A, which target the oxidative and osmotic stress response systems, were elevated by coapplication of certain benzo analogs (aldehydes and acids). Fungal tolerance to 2,3-dihydroxybenzaldehyde or 2,3-dihydroxybenzoic acid was found to rely upon mitochondrial superoxide dismutase (SOD2) or glutathione reductase (GLR1), genes regulated by the HOG1 signaling pathway, respectively. Thus, certain benzo analogs can be effective at targeting cellular oxidative stress response systems. The ability of these compounds to chemosensitize fungi for improved control with conventional antifungal agents is discussed.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18284447     DOI: 10.1111/j.1574-6968.2008.01072.x

Source DB:  PubMed          Journal:  FEMS Microbiol Lett        ISSN: 0378-1097            Impact factor:   2.742


  15 in total

1.  Accumulation of isochorismate-derived 2,3-dihydroxybenzoic 3-O-beta-D-xyloside in arabidopsis resistance to pathogens and ageing of leaves.

Authors:  Michael Bartsch; Paweł Bednarek; Pedro D Vivancos; Bernd Schneider; Edda von Roepenack-Lahaye; Christine H Foyer; Erich Kombrink; Dierk Scheel; Jane E Parker
Journal:  J Biol Chem       Date:  2010-06-10       Impact factor: 5.157

2.  Superoxide dismutases are involved in Candida albicans biofilm persistence against miconazole.

Authors:  Anna Bink; Davy Vandenbosch; Tom Coenye; Hans Nelis; Bruno P A Cammue; Karin Thevissen
Journal:  Antimicrob Agents Chemother       Date:  2011-07-11       Impact factor: 5.191

3.  Chemosensitization of aflatoxigenic fungi to antimycin A and strobilurin using salicylaldehyde, a volatile natural compound targeting cellular antioxidation system.

Authors:  Jong H Kim; Bruce C Campbell; Noreen Mahoney; Kathleen L Chan; Russell J Molyneux
Journal:  Mycopathologia       Date:  2010-08-29       Impact factor: 2.574

4.  Activity of MGCD290, a Hos2 histone deacetylase inhibitor, in combination with azole antifungals against opportunistic fungal pathogens.

Authors:  M A Pfaller; S A Messer; N Georgopapadakou; L A Martell; J M Besterman; D J Diekema
Journal:  J Clin Microbiol       Date:  2009-09-30       Impact factor: 5.948

5.  Chemosensitization of plant pathogenic fungi to agricultural fungicides.

Authors:  Vitaly Dzhavakhiya; Larisa Shcherbakova; Yulia Semina; Natalia Zhemchuzhina; Bruce Campbell
Journal:  Front Microbiol       Date:  2012-03-09       Impact factor: 5.640

6.  Chemosensitization as a means to augment commercial antifungal agents.

Authors:  Bruce C Campbell; Kathleen L Chan; Jong H Kim
Journal:  Front Microbiol       Date:  2012-02-29       Impact factor: 5.640

7.  Targeting the oxidative stress response system of fungi with redox-potent chemosensitizing agents.

Authors:  Jong H Kim; Kathleen L Chan; Natália C G Faria; M de L Martins; Bruce C Campbell
Journal:  Front Microbiol       Date:  2012-03-16       Impact factor: 5.640

8.  A residue-free green synergistic antifungal nanotechnology for pesticide thiram by ZnO nanoparticles.

Authors:  Jingzhe Xue; Zhihui Luo; Ping Li; Yaping Ding; Yi Cui; Qingsheng Wu
Journal:  Sci Rep       Date:  2014-07-14       Impact factor: 4.379

9.  Enhancement of commercial antifungal agents by Kojic Acid.

Authors:  Jong H Kim; Perng-Kuang Chang; Kathleen L Chan; Natália C G Faria; Noreen Mahoney; Young K Kim; Maria de L Martins; Bruce C Campbell
Journal:  Int J Mol Sci       Date:  2012-10-26       Impact factor: 5.923

10.  Enhancement of antimycotic activity of amphotericin B by targeting the oxidative stress response of Candida and cryptococcus with natural dihydroxybenzaldehydes.

Authors:  Jong H Kim; Natália C G Faria; M De L Martins; Kathleen L Chan; Bruce C Campbell
Journal:  Front Microbiol       Date:  2012-07-19       Impact factor: 5.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.